Cargando…

Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy

Detalles Bibliográficos
Autores principales: Maeda, J, Hirano, T, Ogiwara, A, Akimoto, S, Kawakami, T, Fukui, Y, Oka, T, Gong, Y, Guo, R, Inada, H, Nawa, K, Kojika, M, Suga, Y, Ohira, T, Mukai, K, Kato, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2441957/
http://dx.doi.org/10.1038/sj.bjc.6604414
_version_ 1782156651415994368
author Maeda, J
Hirano, T
Ogiwara, A
Akimoto, S
Kawakami, T
Fukui, Y
Oka, T
Gong, Y
Guo, R
Inada, H
Nawa, K
Kojika, M
Suga, Y
Ohira, T
Mukai, K
Kato, H
author_facet Maeda, J
Hirano, T
Ogiwara, A
Akimoto, S
Kawakami, T
Fukui, Y
Oka, T
Gong, Y
Guo, R
Inada, H
Nawa, K
Kojika, M
Suga, Y
Ohira, T
Mukai, K
Kato, H
author_sort Maeda, J
collection PubMed
description
format Text
id pubmed-2441957
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-24419572009-09-10 Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy Maeda, J Hirano, T Ogiwara, A Akimoto, S Kawakami, T Fukui, Y Oka, T Gong, Y Guo, R Inada, H Nawa, K Kojika, M Suga, Y Ohira, T Mukai, K Kato, H Br J Cancer Corrigendum Nature Publishing Group 2008-06-17 2008-06-10 /pmc/articles/PMC2441957/ http://dx.doi.org/10.1038/sj.bjc.6604414 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Corrigendum
Maeda, J
Hirano, T
Ogiwara, A
Akimoto, S
Kawakami, T
Fukui, Y
Oka, T
Gong, Y
Guo, R
Inada, H
Nawa, K
Kojika, M
Suga, Y
Ohira, T
Mukai, K
Kato, H
Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy
title Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy
title_full Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy
title_fullStr Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy
title_full_unstemmed Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy
title_short Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy
title_sort proteomic analysis of stage i primary lung adenocarcinoma aimed at individualization of postoperative therapy
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2441957/
http://dx.doi.org/10.1038/sj.bjc.6604414
work_keys_str_mv AT maedaj proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT hiranot proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT ogiwaraa proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT akimotos proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT kawakamit proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT fukuiy proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT okat proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT gongy proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT guor proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT inadah proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT nawak proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT kojikam proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT sugay proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT ohirat proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT mukaik proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy
AT katoh proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy